Rxsight Historical Balance Sheet

RXST Stock

USD 29.21 0.08 0.27%

Trend analysis of Rxsight balance sheet accounts such as Total Stockholder Equity of 193.6 M, Other Liab of 130.6 M, Net Tangible Assets of 108.6 M or Property Plant And Equipment Net of 12.9 M provides information on Rxsight's total assets, liabilities, and equity, which is the actual value of Rxsight to its prevalent stockholders. By breaking down trends over time using Rxsight balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Rxsight latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Rxsight is a good buy for the upcoming year.

Rxsight Inventory

12.27 Million

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rxsight. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.

About Rxsight Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Rxsight at a specified time, usually calculated after every quarter, six months, or one year. Rxsight Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Rxsight and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Rxsight currently owns. An asset can also be divided into two categories, current and non-current.

Rxsight Balance Sheet Chart

At this time, Rxsight's Capital Lease Obligations is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 911.6 M in 2025, whereas Other Current Liabilities is likely to drop slightly above 9.3 M in 2025.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Rxsight assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Rxsight books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Rxsight balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Rxsight are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Rxsight's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Rxsight current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rxsight. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.At this time, Rxsight's Capital Lease Obligations is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 911.6 M in 2025, whereas Other Current Liabilities is likely to drop slightly above 9.3 M in 2025.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	45.0M	3.0M	3.5M	3.3M
Total Assets	150.2M	182.6M	209.9M	162.0M

Short Long Term Debt Total Total Assets

Rxsight balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Other Stockholder Equity
Total Assets		0.26	0.77	0.85	0.95	-0.81	0.94	-0.92	0.81	0.12	-0.83	0.68	0.61	-0.92	0.27	0.72	0.98	0.82	-0.93	0.77	0.99	-0.94	-0.86	0.82	0.84	0.94
Short Long Term Debt Total	0.26		0.09	0.14	0.33	-0.49	0.41	-0.24	-0.04	0.97	-0.2	-0.35	0.72	-0.22	0.55	-0.06	0.33	-0.02	-0.3	-0.27	0.24	-0.36	0.18	0.07	0.53	0.29
Other Current Liab	0.77	0.09		0.98	0.78	-0.85	0.74	-0.87	0.88	0.04	-0.84	0.75	0.26	-0.89	0.32	0.73	0.63	0.89	-0.67	0.89	0.66	-0.79	-0.84	0.96	0.38	0.79
Total Current Liabilities	0.85	0.14	0.98		0.86	-0.85	0.83	-0.93	0.91	0.08	-0.9	0.81	0.29	-0.93	0.43	0.84	0.72	0.91	-0.8	0.88	0.76	-0.87	-0.9	0.99	0.47	0.87
Total Stockholder Equity	0.95	0.33	0.78	0.86		-0.89	0.99	-0.98	0.89	0.22	-0.94	0.6	0.63	-0.97	0.47	0.7	0.92	0.9	-0.97	0.69	0.91	-1.0	-0.83	0.83	0.8	1.0
Other Liab	-0.81	-0.49	-0.85	-0.85	-0.89		-0.88	0.9	-0.8	-0.39	0.84	-0.4	-0.7	0.91	-0.44	-0.49	-0.76	-0.82	0.77	-0.63	-0.73	0.9	0.65	-0.79	-0.68	-0.88
Net Tangible Assets	0.94	0.41	0.74	0.83	0.99	-0.88		-0.96	0.84	0.3	-0.92	0.56	0.66	-0.95	0.51	0.69	0.92	0.85	-0.98	0.63	0.91	-1.0	-0.79	0.8	0.82	0.99
Property Plant And Equipment Net	-0.92	-0.24	-0.87	-0.93	-0.98	0.9	-0.96		-0.95	-0.15	0.96	-0.69	-0.51	1.0	-0.49	-0.77	-0.85	-0.95	0.93	-0.79	-0.86	0.98	0.88	-0.91	-0.67	-0.99
Current Deferred Revenue	0.81	-0.04	0.88	0.91	0.89	-0.8	0.84	-0.95		-0.11	-0.93	0.76	0.3	-0.95	0.39	0.75	0.71	1.0	-0.83	0.85	0.74	-0.88	-0.92	0.9	0.47	0.91
Net Debt	0.12	0.97	0.04	0.08	0.22	-0.39	0.3	-0.15	-0.11		-0.14	-0.38	0.56	-0.12	0.65	-0.06	0.17	-0.1	-0.2	-0.35	0.09	-0.25	0.26	0.04	0.35	0.18
Retained Earnings	-0.83	-0.2	-0.84	-0.9	-0.94	0.84	-0.92	0.96	-0.93	-0.14		-0.67	-0.41	0.95	-0.54	-0.75	-0.75	-0.93	0.91	-0.71	-0.77	0.95	0.86	-0.89	-0.57	-0.95
Accounts Payable	0.68	-0.35	0.75	0.81	0.6	-0.4	0.56	-0.69	0.76	-0.38	-0.67		-0.16	-0.69	0.17	0.93	0.55	0.74	-0.63	0.9	0.64	-0.6	-0.93	0.86	0.21	0.63
Cash	0.61	0.72	0.26	0.29	0.63	-0.7	0.66	-0.51	0.3	0.56	-0.41	-0.16		-0.52	0.16	-0.04	0.72	0.33	-0.55	0.09	0.62	-0.62	-0.16	0.19	0.89	0.59
Non Current Assets Total	-0.92	-0.22	-0.89	-0.93	-0.97	0.91	-0.95	1.0	-0.95	-0.12	0.95	-0.69	-0.52		-0.44	-0.74	-0.85	-0.96	0.92	-0.81	-0.86	0.97	0.89	-0.91	-0.67	-0.98
Non Currrent Assets Other	0.27	0.55	0.32	0.43	0.47	-0.44	0.51	-0.49	0.39	0.65	-0.54	0.17	0.16	-0.44		0.5	0.22	0.36	-0.52	0.04	0.21	-0.5	-0.23	0.46	0.16	0.49
Other Assets	0.72	-0.06	0.73	0.84	0.7	-0.49	0.69	-0.77	0.75	-0.06	-0.75	0.93	-0.04	-0.74	0.5		0.61	0.73	-0.76	0.77	0.69	-0.71	-0.88	0.89	0.31	0.72
Cash And Short Term Investments	0.98	0.33	0.63	0.72	0.92	-0.76	0.92	-0.85	0.71	0.17	-0.75	0.55	0.72	-0.85	0.22	0.61		0.72	-0.91	0.64	0.99	-0.9	-0.76	0.69	0.93	0.9
Net Receivables	0.82	-0.02	0.89	0.91	0.9	-0.82	0.85	-0.95	1.0	-0.1	-0.93	0.74	0.33	-0.96	0.36	0.73	0.72		-0.83	0.86	0.75	-0.89	-0.91	0.9	0.5	0.92
Common Stock Total Equity	-0.93	-0.3	-0.67	-0.8	-0.97	0.77	-0.98	0.93	-0.83	-0.2	0.91	-0.63	-0.55	0.92	-0.52	-0.76	-0.91	-0.83		-0.62	-0.92	0.97	0.82	-0.79	-0.79	-0.97
Common Stock Shares Outstanding	0.77	-0.27	0.89	0.88	0.69	-0.63	0.63	-0.79	0.85	-0.35	-0.71	0.9	0.09	-0.81	0.04	0.77	0.64	0.86	-0.62		0.7	-0.68	-0.93	0.89	0.34	0.71
Short Term Investments	0.99	0.24	0.66	0.76	0.91	-0.73	0.91	-0.86	0.74	0.09	-0.77	0.64	0.62	-0.86	0.21	0.69	0.99	0.75	-0.92	0.7		-0.9	-0.82	0.73	0.88	0.9
Non Current Liabilities Total	-0.94	-0.36	-0.79	-0.87	-1.0	0.9	-1.0	0.98	-0.88	-0.25	0.95	-0.6	-0.62	0.97	-0.5	-0.71	-0.9	-0.89	0.97	-0.68	-0.9		0.82	-0.84	-0.78	-1.0
Capital Lease Obligations	-0.86	0.18	-0.84	-0.9	-0.83	0.65	-0.79	0.88	-0.92	0.26	0.86	-0.93	-0.16	0.89	-0.23	-0.88	-0.76	-0.91	0.82	-0.93	-0.82	0.82		-0.92	-0.47	-0.85
Inventory	0.82	0.07	0.96	0.99	0.83	-0.79	0.8	-0.91	0.9	0.04	-0.89	0.86	0.19	-0.91	0.46	0.89	0.69	0.9	-0.79	0.89	0.73	-0.84	-0.92		0.41	0.85
Other Current Assets	0.84	0.53	0.38	0.47	0.8	-0.68	0.82	-0.67	0.47	0.35	-0.57	0.21	0.89	-0.67	0.16	0.31	0.93	0.5	-0.79	0.34	0.88	-0.78	-0.47	0.41		0.76
Other Stockholder Equity	0.94	0.29	0.79	0.87	1.0	-0.88	0.99	-0.99	0.91	0.18	-0.95	0.63	0.59	-0.98	0.49	0.72	0.9	0.92	-0.97	0.71	0.9	-1.0	-0.85	0.85	0.76

Click cells to compare fundamentals

Rxsight Account Relationship Matchups

Rxsight balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	100.7M	192.7M	150.2M	182.6M	209.9M	162.0M
Short Long Term Debt Total	30.8M	44.9M	45.0M	3.0M	3.5M	3.3M
Other Current Liab	9.2M	5.7M	9.4M	13.2M	15.2M	9.3M
Total Current Liabilities	11.6M	11.1M	17.2M	20.9M	24.0M	15.2M
Total Stockholder Equity	(297.5M)	138.2M	89.9M	160.4M	184.4M	193.6M
Property Plant And Equipment Net	18.6M	15.5M	14.1M	13.3M	12.0M	12.9M
Current Deferred Revenue	438K	618K	1.3M	2.0M	2.4M	2.5M
Net Debt	16.8M	20.6M	33.2M	(6.7M)	(7.7M)	(7.3M)
Retained Earnings	(430.6M)	(479.3M)	(546.0M)	(594.6M)	(535.2M)	(561.9M)
Accounts Payable	1.1M	1.7M	2.6M	3.9M	4.4M	2.5M
Cash	14.0M	24.4M	11.8M	9.7M	11.1M	14.9M
Non Current Assets Total	19.2M	16.4M	15.6M	14.1M	12.7M	13.7M
Non Currrent Assets Other	110K	114K	767K	147K	169.1K	274.8K
Cash And Short Term Investments	69.0M	159.3M	105.8M	127.2M	146.3M	119.2M
Net Receivables	2.9M	4.9M	11.0M	20.3M	23.3M	24.5M
Short Term Investments	55.0M	135.0M	94.0M	117.5M	135.1M	104.3M
Liabilities And Stockholders Equity	100.7M	192.7M	150.2M	182.6M	209.9M	162.0M
Non Current Liabilities Total	386.6M	43.4M	43.0M	1.3M	1.2M	1.1M
Capital Lease Obligations	6.4M	5.2M	4.8M	3.0M	2.7M	4.0M
Inventory	8.3M	8.0M	14.8M	17.4M	20.0M	12.3M
Other Current Assets	1.4M	8.1M	3.0M	3.5M	4.1M	3.9M
Other Stockholder Equity	(301.0M)	617.5M	636.0M	755.0M	868.2M	911.6M
Total Liab	398.2M	54.5M	60.3M	22.2M	20.0M	19.0M
Net Invested Capital	(273.1M)	178.0M	130.1M	160.4M	184.4M	193.6M
Property Plant And Equipment Gross	18.6M	15.5M	10.1M	36.0M	41.4M	21.9M
Total Current Assets	81.5M	176.3M	134.6M	168.4M	193.7M	143.2M
Accumulated Other Comprehensive Income	(3K)	(20K)	(95K)	(5K)	(4.5K)	(4.7K)
Capital Stock	80.8M	27K	28K	36K	32.4K	30.8K
Net Working Capital	69.9M	165.2M	117.3M	147.5M	169.6M	128.0M
Short Term Debt	1.3M	3.1M	3.9M	1.8M	2.1M	2.4M
Common Stock	80.8M	27K	28K	36K	32.4K	30.8K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Rxsight Stock Analysis

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Rxsight Historical Balance Sheet

Rxsight Inventory

12.27 Million

About Rxsight Balance Sheet Analysis

Rxsight Balance Sheet Chart

Total Assets

Total Current Liabilities

Rxsight balance sheet Correlations

Rxsight Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Rxsight balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Rxsight Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Stockholder Equity	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Net Receivables	+ 1.0	Current Deferred Revenue
Short Term Investments	+ 0.99	Total Assets
Inventory	+ 0.99	Total Current Liabilities
Net Tangible Assets	+ 0.99	Total Stockholder Equity

Other Stockholder Equity	- 1.0	Non Current Liabilities Total
Non Current Liabilities Total	- 1.0	Net Tangible Assets
Non Current Liabilities Total	- 1.0	Total Stockholder Equity
Other Stockholder Equity	- 0.99	Property Plant And Equipment Net
Other Stockholder Equity	- 0.98	Non Current Assets Total
Common Stock Total Equity	- 0.98	Net Tangible Assets